Wanbury Limited
NSE: WANBURY | Information Technology
Market Fundamentals
Stock Intelligence & News
Wanbury Ltd (524212)
Trading Window Closure for the Quarter ended 30th September, 2026.
Read Full Analysis →Wanbury Limited
Wanbury Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →Wanbury Limited
Wanbury Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the company has informed the Exchange regarding voting results. |SUBJECT: Shareholders meeting
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Wanbury Ltd (524212)
Proceedings of the 38th Annual General Meeting of the Company held on Thursday, September 24, 2026 through VC/OAVM
Read Full Analysis →Wanbury Limited
Wanbury Limited has informed the Exchange about Copy of Newspaper Publication: Information regarding 38th Annual General Meeting to be held through Video Conferencing (VC)/Other Audio Visual Means (OAVM). |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Wanbury Ltd (524212)
The register of members and share transfer books of the Company will remain closed from Friday, 18 September, 2026 to Thursday, 24 September, 2026 (both days inclusive) for the purpose of Annual General Meeting.
Read Full Analysis →Wanbury Limited
Wanbury Limited has informed the Exchange that Record date for the purpose of Meeting is 18-Sep-2026. |SUBJECT: Record Date
Read Full Analysis →Wanbury Limited
Wanbury Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Wanbury Ltd (524212)
Press Release regarding EDQM approval for new product Rivaroxaban API, USFDA DMF Clearances.
Read Full Analysis →Wanbury Limited
Wanbury Limited has informed the Exchange regarding a press release dated August 13, 2026, titled "Press Release regarding EDQM Approval for new product Rivaroxaban API,USFDA DMF Clearances". |SUBJECT: Press Release
Read Full Analysis →Get instant alerts when WANBURY breaks news
Join investors who track Wanbury Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for WANBURY?
WANBURY is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Wanbury Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding WANBURY to your custom watchlist.